supp.fit

Selenium and Coenzyme Q10: study protocols

20 study groups took Selenium together with Coenzyme Q10. These are the doses the studies gave. They are not a recommendation.

Selenium: what the research found →

Dose per serving from research: Selenium

20 study groups in 19 studies say how much Selenium participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mcg to 250 mcg, 75% of 20 study groups.

Daily doseStudy groups
25 mcg to 50 mcg
2
50 mcg to 100 mcg
1
100 mcg to 250 mcg
15
250 mcg to 500 mcg
1
over 500 mcg
1

Dose per serving from research: Coenzyme Q10

20 study groups in 19 studies say how much Coenzyme Q10 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 100 mg to 250 mg, 80% of 20 study groups.

Daily doseStudy groups
25 mg to 50 mg
3
50 mg to 100 mg
1
100 mg to 250 mg
16

Commonly used together

3 of 20 study groups took Selenium and Coenzyme Q10 with something else, but nothing that 3 or more different studies gave.

20 study groups

Study
Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens
2015 · Active treatment · Elderly Swedish community-dwelling adults; mean age 78 years; men and women; described as healthy, with low baseline selenium status
200 mcg200 mg4 years221
Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly
2018 · Active treatment group · Elderly healthy Swedish community-dwelling adults; mean age 78 years, men and women
200 mcg200 mg1461 days221
Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial
2016 · active treatment group · Adults aged 70–80 years in Sweden, without a stated requirement for a diagnosed condition; participants were analysed in strata by baseline serum selenium concentration.
200 mcg200 mg4 years219
Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden
2022 · Active treatment group · Adults aged 70–88 years with low selenium status and age-related low coenzyme Q10 levels
400 mcg200 mg4 years221
Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study
2015 · active substance group · community-dwelling elderly adults; mean age 77 years; 51% male
200 mcg200 mg1461 days221
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · EP1 · Patients with severe erythrodermic psoriasis
48 mcg50 mg30 days—
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · PsA1 · Patients with severe arthropathic psoriasis
48 mcg50 mg5 weeks—
Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
2017 · active treatment · Elderly healthy Swedish adults, mean age about 76 years; both sexes; some had hypertension, ischemic heart disease, or diabetes
200 mcg200 mg1461 days117
Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality
2024 · selenium yeast and coenzyme Q 10 supplementation · elderly community-living participants with low selenium status
200 mcg200 mg4 years—
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 · Active treatment · Adults aged 70–88 years from an elderly Swedish community population; no condition required for inclusion
200 mcg200 mg1461 days221
Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population
2019 · SeQ10 active treatment group · Men aged 70–88 from a healthy elderly community-living population
200 mcg200 mg4 years221
Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial
2023 · Active treatment · Elderly community-dwelling Swedes with low selenium status; age range not stated at intervention
200 mcg200 mg1461 days220
Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q(10) in an Elderly Swedish Population: A Sub-Analysis
2022 · active treatment group · Swedish adults aged 70–88 with low selenium status
200 mcg200 mg1461 days118
Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial
2020 · Active supplementation with selenium and coenzyme Q10 · Adults aged 70–88 years with low pre-intervention selenium status, living in the community
200 mcg200 mg1461 days117
Dietary Supplementation with Selenium and Coenzyme Q(10) Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population
2021 · Active treatment · Adults aged 70–88 years living in a Swedish rural community, with suboptimal serum selenium status; the analysed group excluded people with atrial fibrillation or anticoagulant treatment, malignancy, or left atrium dimension over 40 mm.
200 mcg200 mg4 years106
Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
2022 · active treatment · Adults aged over 69 years living in a rural municipality in Sweden, with low selenium status; elderly population
200 mcg200 mg4 years67
Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens
2017 · Active treatment · Men aged 70–80 years in a community-based elderly population; some had hypertension or ischemic heart disease, and many had low selenium status
200 mcg200 mg4 years25
Selenium and coenzyme Q(10) improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals
2023 · selenium and coenzyme Q10 supplementation · Elderly community-dwelling individuals with low levels of selenium and coenzyme Q10
200 mcg200 mg4 years—
Coenzyme Q10 and antioxidants in acute myocardial infarction
1994 · verum group · Patients admitted with acute myocardial infarction and symptom duration under 6 hours
600 mcg100 mg1 year32
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial
2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS)
70 mcg30 mg90 days30